NBPF3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.695200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.417600E-01
Normal-vs-Stage2
7.154000E-01
Normal-vs-Stage3
4.750000E-01
Normal-vs-Stage4
3.620600E-01
Stage1-vs-Stage2
7.465800E-01
Stage1-vs-Stage3
1.158840E-01
Stage1-vs-Stage4
5.408200E-01
Stage2-vs-Stage3
1.663420E-01
Stage2-vs-Stage4
3.798000E-01
Stage3-vs-Stage4
9.142300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.855800E-01
Normal-vs-AfricanAmerican
7.862400E-02
Normal-vs-Asian
7.993200E-01
Caucasian-vs-AfricanAmerican
1.916360E-02
Caucasian-vs-Asian
2.574400E-01
AfricanAmerican-vs-Asian
2.480700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.151000E-01
Normal-vs-Female
6.234400E-01
Male-vs-Female
4.892000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.967800E-01
Normal-vs-Age(41-60Yrs)
4.253400E-01
Normal-vs-Age(61-80Yrs)
7.677000E-01
Normal-vs-Age(81-100Yrs)
3.047600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.648600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.824400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.822800E-03
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.869600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.98739999999998E-05
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.800100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.647800E-01
Normal-vs-Daily Drinker
8.000600E-01
Normal-vs-Weekly Drinker
7.029200E-01
Normal-vs-Occasional Drinker
5.102800E-01
Normal-vs-Social Drinker
4.529800E-01
Non Drinker-vs-Daily Drinker
5.661200E-01
Non Drinker-vs-Weekly Drinker
4.396000E-01
Non Drinker-vs-Occasional Drinker
1.236610E-01
Non Drinker-vs-Social Drinker
1.139630E-01
Daily Drinker-vs-Weekly Drinker
9.531000E-01
Daily Drinker-vs-Occasional Drinker
5.484600E-01
Daily Drinker-vs-Social Drinker
2.262800E-01
Weekly Drinker-vs-Occasional Drinker
5.644000E-01
Weekly Drinker-vs-Social Drinker
2.626800E-01
Occasional Drinker-vs-Social Drinker
4.593600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.031800E-01
Normal-vs-Grade 2
1.627240E-01
Normal-vs-Grade 3
2.087200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.315600E-01
Grade 1-vs-Grade 3
8.324600E-01
Grade 1-vs-Grade 4
4.031800E-01
Grade 2-vs-Grade 3
9.830000E-01
Grade 2-vs-Grade 4
1.627240E-01
Grade 3-vs-Grade 4
2.087200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.455800E-01
Normal-vs-NonDiabetic
6.475800E-01
Diabetic-vs-NonDiabetic
1.226960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.171200E-01
Normal-vs-NoPancreatitis
7.055800E-01
Pancreatitis-vs-NoPancreatitis
5.685200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.079800E-01
Normal-vs-N1
7.309600E-01
N0-vs-N1
3.266000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.871800E-01
Normal-vs-TP53-NonMutant
3.979000E-01
TP53-Mutant-vs-TP53-NonMutant
3.342800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
